Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Compass Therapeutics, Inc. | 90,000 | reported | 02 Jan 2026 | tx 5+255,000 |
| BioAtla, Inc. | 77,397 | reported | 18 Jun 2025 | tx 9+147,397 |
| GTC BIOTHERAPEUTICS INC | 45,000 | reported | 24 Jun 2008 | tx 3+70,000 |
| SELLAS Life Sciences Group, Inc. | 39,167 | reported | 10 Oct 2017 | tx 7+341,678 |
| TETRALOGIC PHARMACEUTICALS CORP | 30,000 |
| reported |
| 28 Jan 2015 |
| tx 2+30,000 |
| TELIK INC | 10,000 | reported | 22 May 2008 | tx 4+25,000 |
| Keros Therapeutics, Inc. | 7,433 | reported | 03 Jun 2026 | tx 9+83,498 |
| PALISADE BIO, INC. | 5,820 | reported | 21 Nov 2023 | tx 7+90,300 |
| Sarepta Therapeutics, Inc. | 5,077 | reported | 07 Mar 2022 | tx 16+38,393−2,901 |
| SENOMYX INC | 0 | reported | 02 Nov 2018 | tx 13+178,750−50,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jun 2026 | GRANT_AWARD | Keros Therapeutics, Inc. | 7,142 | 0.00 USD | |
| 03 Jun 2026 | GRANT_AWARD | Keros Therapeutics, Inc. | 7,433 | 0.00 USD | deriv |
| 03 Mar 2026 | TENDER | RAPT Therapeutics, Inc. | 4,956 | — | |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 478 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 32,229 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 7,650 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 4,561 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 1,072 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 1,618 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 560 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 1,063 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 484 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 938 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 2,813 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 498 | — | deriv |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 938 | — | deriv |
| 30 Jan 2026 | GRANT_AWARD | RAPT Therapeutics, Inc. | 4,956 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | BioAtla, Inc. | 23,500 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 5,250 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | RAPT Therapeutics, Inc. | 257,832 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | RAPT Therapeutics, Inc. | 61,202 | 1.06 USD | deriv |
| 11 Feb 2025 | GRANT_AWARD | Compass Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | BioAtla, Inc. | 16,500 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 24 Mar 2017.